AMTZ moves to build ‘Device’ to rate Buildings on Accessibility Quotient

Disable Friendly building scheme- Born in Vizag today

Visakhapatnam:  All buildings in the making must factor in accessibility aspect for disabled persons. AMTZ (Andhra Pradesh MedTech Zone), the biggest world class medical device manufacturing cluster here, today leads the movement for ensuring global grade buildings in India as well. India’s First Accessibility Certification Scheme will come into being out of a two day high level national consultation beginning today

In a landmark step toward transforming India’s built environment into inclusive and accessible spaces for all, AMTZ is hosting this national consultation to develop the country’s first Purple Building Certification Scheme — a dedicated accessibility rating system for buildings.

More than 50 leading national experts in accessibility, disability rights, architecture, and urban planning got together at the AMTZ campus to deliberate and finalize the framework. The certification is aimed at ensuring that public and private buildings across India are designed and operated in ways that are truly accessible for persons with disabilities, senior citizens, pregnant women, and all users with mobility and sensory needs.

The Purple Building Certification Scheme is being designed as a structured, scalable tool that will assess buildings based on universal design principles. It will include detailed checklists, tiered ratings (basic to excellence), and measurable benchmarks covering entrances, ramps, signage, washrooms, elevators, pathways, and digital accessibility.

“Accessibility should not be seen as an exception, but as the foundation of every building in a truly inclusive nation. With the Purple Building Certification, AMTZ is proud to lead a national movement that redefines how India builds—ensuring dignity, safety, and equal access for all including Divyangjans.” says Dr. Jitendra Sharma, MD & Founder CEO, AMTZ.

This two-day three expert committees are meeting to build a national standard for accessibility. Once adopted, Purple Certification will serve as a voluntary yet widely recognized benchmark for schools, hospitals, shopping complexes, corporate offices, and even housing societies. AMTZ’s role goes beyond certification. It is already a national partner in the ongoing Sugamya Delhi Abhiyan — a people-led campaign spearheaded by Inclusive Divyangjan Entrepreneurs Association (IDEA) and now supported by the Delhi Government. The Purple Certification scheme is envisioned as a core tool within that campaign to institutionalize accessibility across public spaces.

Experts believe the Purple Building Certification could be a game-changer—filling the long-standing gap between progressive laws and real-world implementation. By uniting the government, private sector, civil society, and persons with disabilities, the scheme aims to build truly inclusive cities.

  • Related Posts

    Bee might have bared Fangs like Death for Karishma Kapoor’s Ex Hubby

    It is assumed bee bite could have triggered fatal heart attack in Sanjay Kapoor Delhi/London:  It is not a wild guess that bee sting might have caused fatal heart attack…

    FUJIFILM resolves to detect Breast Cancer early with Apollo Hospitals

    Telugu Actor Ram Charan’s Wife & Apollo Patriarch’s Scion acts as Ambassador Hyderabad:  FUJIFILM India, a leader in healthcare technology, has launched its latest CSR campaign, ‘Find It Early, Fight…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Pharma stock jumps after receiving approval from UK’s MHRA to sell new pharma product

    Pharma stock jumps after receiving approval from UK’s MHRA to sell new pharma product

    HIV prevention drug hailed as a ‘breakthrough’ gets FDA approval

    HIV prevention drug hailed as a ‘breakthrough’ gets FDA approval

    ED raids three pharma units in Baddi, Nalagarh

    ED raids three pharma units in Baddi, Nalagarh

    Glenmark Pharma: FDA concludes inspection at US facility, issues five observations

    Glenmark Pharma: FDA concludes inspection at US facility, issues five observations